The lab has a diversified Revenue Stream from Toxicology, Women’s Health, UTI, Covid, and Respiratory Panel Testing. The lab is well-positioned to continue to grow post-Covid. Projected 2021 Revenue: $6M, EBITDA: $2M.
The Company is specialized in the design, assembly, service, programming and certification of flow rate calibration equipment. Revenue: $1.87M; EBITDA: $650K (proj. for next 12 months).
4.000 sq. ft of lab space available for lease as of Dec 1, 2020. Currently running as a clinical lab doing toxicology and other clinical testing.
The Lab has very stable revenues, is consistently profitable with high EBITDA margins and offers a high growth opportunity. Revenue: $1.21M; EBITDA: $608K; asking price: $2.25M.
12,500 sq. ft. Research Lab with Wet-Lab capability, formerly occupied by Sherwin Williams R&D group. Immediately available. Many first-class amenities. Two Acre property. Auction Reserve Price: $375K; Original Price: $795,000.
New Toxicology lab in NC. With Medicare and NC Medicaid, high complexity CLIA. Can be Covid-Testing ready in 4-8 weeks. Asking Price $375K.